Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00394758 · ClinicalTrials.gov registry record · Phase 3

A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia

A Phase 3 study of Vulvar Dysplasia and Vaginal Dysplasia, sponsored by University Hospitals Cleveland Medical Center.

Completed
Registry status
Phase 3
Development phase
150
Enrollment target
1
Study location

NCT00394758 is a Phase 3 study of Vulvar Dysplasia and Vaginal Dysplasia that has completed, run by University Hospitals Cleveland Medical Center. The registered enrollment target is 150 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00394758, a Phase 3 study of Vulvar Dysplasia and Vaginal Dysplasia, has completed, sponsored by University Hospitals Cleveland Medical Center.

COMPLETED
Registry status
Phase 3
Development phase
150 participants
Enrollment target
1
Study location

Study Summary

1. To compare the recurrence rate between the use of laser vaporization and ultrasonic surgical aspiration in the treatment of vulvar and vaginal dysplasias 2. To compare healing related complications, post-operative pain, and scarring between the two procedures.

Interventions

  • PROCEDURE CO2 laser surgery
  • PROCEDURE ultrasonic surgical aspiration

Study Locations (1)

Ohio

  • University Hospitals of Cleveland - Cleveland

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2000-01-01
Est. Completion 2005-12-31
Phase Phase 3

What the Registry Record Tells You About NCT00394758

The ClinicalTrials.gov registry entry for NCT00394758 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University Hospitals Cleveland Medical Center, which has 230 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Vulvar Dysplasia appearing as the primary indexed condition, and to 2 interventions - of which CO2 laser surgery is the first listed.

NCT00394758 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT00394758 about?

NCT00394758 is a clinical study titled "A Randomized Trial of Surgical Treatments for Vulvar and Vaginal Dysplasia". 1. To compare the recurrence rate between the use of laser vaporization and ultrasonic surgical aspiration in the treatment of vulvar and vaginal dysplasias 2. To compare healing related complications, post-operative pain, and scarring between the two procedures.

What is the current status of trial NCT00394758?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 150 participants. The study started on 2000-01-01. Estimated completion is 2005-12-31.

What conditions does trial NCT00394758 study?

This clinical trial studies the following conditions: Vulvar Dysplasia, Vaginal Dysplasia.

What interventions are being tested in trial NCT00394758?

The interventions under investigation include: CO2 laser surgery (PROCEDURE), ultrasonic surgical aspiration (PROCEDURE).

Who is sponsoring clinical trial NCT00394758?

This trial is sponsored by University Hospitals Cleveland Medical Center, which has 230 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00394758 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.